SelectQuote (NYSE:SLQT) Director Donald Hawks III Acquires 223,402 Shares of Stock

SelectQuote, Inc. (NYSE:SLQT – Get Free Report) Director Donald Hawks III bought 223,402 shares of SelectQuote stock in a transaction dated Monday, November 9th. The shares were bought at an average cost of $0.46 per share, with a total value of $102,764.92. Following the completion of the transaction, the director directly owned 763,214 shares in the company, valued at approximately $351,078.44. This trade represents a 41.39% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

SelectQuote Trading Up 2.6%

Shares of SLQT stock opened at $0.46 on Wednesday. The company has a 50 day moving average of $0.42 and a 200-day moving average of $0.75. The company has a quick ratio of 7.48, a current ratio of 7.48 and a debt-to-equity ratio of 1.16. SelectQuote, Inc. has a 12-month low of $0.30 and a 12-month high of $1.76. The firm has a market cap of $82.36 million, a P/E ratio of 44.73 and a beta of 2.01.

SelectQuote (NYSE:SLQT – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.12. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. The company had revenue of $280.01 million for the quarter, compared to analysts’ expectations of $277.91 million. Sell-side analysts anticipate that SelectQuote, Inc. will post -0.25 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Wall Street Zen cut SelectQuote from a “hold” rating to a “sell” rating in a research report on Saturday, August 29th. Weiss Ratings downgraded SelectQuote from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, August 17th. Finally, Zacks Research raised SelectQuote from a “strong sell” rating to a “hold” rating in a report on Monday, October 26th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, SelectQuote currently has an average rating of “Hold” and an average target price of $3.00.

Read Our Latest Research Report on SLQT

Institutional Trading of SelectQuote

Institutional investors have recently modified their holdings of the business. SMH Capital Advisors Inc. bought a new position in SelectQuote in the 3rd quarter worth approximately $47,000. EP Wealth Advisors LLC purchased a new stake in shares of SelectQuote during the second quarter worth $51,000. Persistent Asset Partners Ltd bought a new position in shares of SelectQuote in the second quarter worth $57,000. State of Wyoming boosted its holdings in shares of SelectQuote by 103.4% in the first quarter. State of Wyoming now owns 95,382 shares of the company’s stock worth $60,000 after acquiring an additional 48,483 shares during the period. Finally, Fragasso Financial Advisors Inc bought a new position in shares of SelectQuote in the third quarter worth $61,000. 34.59% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about SelectQuote

Here are the key news stories impacting SelectQuote this week:

  • Positive Sentiment: Executives and directors bought a combined 919,905 shares for about $447,000 in transactions on November 6 and 9. Purchasers included the CEO, president, COO, and two directors; the largest reported purchase was 409,836 shares by Director Raymond F. Weldon. Broad insider buying may signal confidence, though it does not guarantee improved results. SEC filing SEC filing
  • Neutral Sentiment: A report says SelectQuote placed fewer Medicare policies but earned more on each one. Higher per-policy earnings may partly offset weaker policy volume, but the article details provided do not establish the overall effect on revenue or profit. SelectQuote places fewer Medicare policies but earns more on each one

About SelectQuote

(Get Free Report)

SelectQuote, Inc. (NYSE: SLQT) operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs. SelectQuote’s primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.

Featured Stories

Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.